Geron's Stem-Cell Exit Arose From Financial Uncertainty - Wall Street Journal

raisavydyexuwowi.blogspot.com

Geron's Stem-Cell Exit Arose From Financial Uncertainty Wall Street Journal Geron Corp. attributed its decision to exit embryonic stem cell research to financial constraints rather than any scientific setbacks in the emerging and controversial research field. The Menlo Park, Calif., company cited "capital ... and more »